Medley Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1975.

1975 Mumbai, Maharashtra, India Active

Last Updated: December 29, 2025

About Medley Pharmaceuticals Limited

Medley Pharmaceuticals Limited, a active public limited company, was established on 15 April 1975 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1975PLC018296. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹33.00 Cr and a paid-up capital of ₹30.06 Cr.

Formerly known as Medley Pharmaceuticals Private Limited. It upholds a compliant status. Employing 2,852 professional, Its leadership includes Ravindra Baliram More (Company Secretary), Sahir Sami Khatib (Managing Director), Mohamed Aslam Abdul Rahman Sheikh (Director). Past directors included Firdaus Jehangir Tarachand, Mayank Bhargava, Vimalkumar Shyam Varma. It holds ₹57.40 Cr open charges and ₹254.55 Cr settled loans. Its latest AGM occurred on 17 September 2025, with the balance sheet filed on 31 March 2025. It is based at Medley Housed 2 M I D C Area Andheri (East), Mumbai, Maharashtra, 400093.

Company Details

CIN/LLPIN
U24230MH1975PLC018296
Registration Number
018296
Incorporation Date
15 April 1975
Authorized Capital
₹33.00 Cr
Paid-Up Capital
₹30.06 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 33.00 Cr as on 29-12-2025
Paid Up Capital ₹ 30.06 Cr as on 29-12-2025
Company Age 50 Year, 10 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 57.40 Cr as on 29-12-2025
Satisfied Charges ₹ 254.55 Cr as on 29-12-2025
Revenue Growth **** 10.68% (FY 2024)
Profit Growth **** 22.34% (FY 2024)
Ebitda **** 15.26% (FY 2024)
Net Worth 13.00% (FY 2024)
Total Assets **** 12.22% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Medley Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Medley Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ravindra Baliram More	Company Secretary	01 Dec 2014	Current
Sahir Sami Khatib	Managing Director	01 Apr 2015	Current
Mohamed Aslam Abdul Rahman Sheikh	Director	28 Jun 2024	Current
Saba Mir Asif Ali	Whole-Time Director	24 Feb 2015	Current
Suhel Sami Khatib	Director	01 Apr 2010	Current
Sarosh Sami Khatib	Whole-Time Director	17 Jul 1987	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Cfo	30 Sep 2022	Past
Pramod Abcsdd	Company Secretary	14 Aug 2009	Past
Pramod Abcsdd	Director	21 Apr 2012	Past
Pramod Abcsdd	Ceo	-	Past
Pramod Abcsdd	Director	13 Feb 2017	Past
Pramod Abcsdd	Additional Director	01 Sep 2012	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medley Pharmaceuticals.

Medley Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 10.68% increase. The company also saw a substantial improvement in profitability, with a 22.34% increase in profit. The company's net worth Soared by an impressive increase of 13%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

10.68%

*******

Revenue from Operations

*******

8.81%

*******

Total Assets

*******

12.22%

*******

Profit or Loss

*******

22.34%

*******

Net Worth

*******

13.00%

*******

EBITDA

*******

15.26%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medley Pharmaceuticals?

In 2024, Medley Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹574,000,000.00

Satisfied Charges

₹2,545,450,000.00

Charges Breakdown by Lending Institutions

Others : 40.10 Cr
State Bank Of India : 17.30 Cr

Latest Charge Details

Date	Lender	Amount	Status
02 Dec 2025	Others	₹20.00 Cr	Open
17 Jun 2022	Others	₹20.00 Cr	Open
15 Apr 2021	Others	₹1.00 M	Open
31 Mar 1999	State Bank Of India	₹17.30 Cr	Open
30 Mar 2015	Icici Bank Limited	₹6.50 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Medley Pharmaceuticals?

Medley Pharmaceuticals has a workforce of 2852 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Medley Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medley Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medley Pharmaceuticals

Recent Activity within the Organization

Charges

A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101198123 was registered on 02 Dec 2025. was recorded as a recent event.
02 Dec 2025
Annual General Meeting

Medley Pharmaceuticals Limited last Annual general meeting of members was held on 17 Sep 2025 as per latest MCA records. was recorded as a recent event.
17 Sep 2025
Balance Sheet

Medley Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025
Director Appointment

Sucheta Mudgerikar was appointed as a Director was appointed as a Director on 25 Jul 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
25 Jul 2024
Charges

The activity A charge with Others of Rs. 20.00 Cr registered on 17 Jun 2022 with Charge ID 100589116 was modified on 08 Jul 2024. was completed.
08 Jul 2024
Director Appointment

Progress on Mohamed Aslam Abdul Rahman Sheikh was appointed as a Director was appointed as a Director on 28 Jun 2024 & has been associated with this company since 1 year 8 months . was documented.
28 Jun 2024

Explore recent activity and updates - View Recent Activity